Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Voyageur Pharmaceuticals Ltd

VM.V ✓ COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Pharmaceuticals ·

Canada Micro Cap Analyst: N/A

Last Close

$0.12

▼ -5.88%

Market Cap $26.00M · Vol 104.31K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$26.00M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

66.67

Momentum

Beta

0.37

vs Market

52W High

$0.14

19.03% below

52W Low

$0.05

127.06% above

Volume

104.31K

Avg 186.78K

P/B

22.81

Price-to-book

ROE

N/A

Return on equity

Free Float

92.53%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Voyageur Pharmaceuticals Ltd (VM.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does VM.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.23%

+14.29%

+68.42%

+14.29%

YTD

-5.88%

+158.32%

+88.24%

Financials & Valuation

TTM · Annual

Total Revenue	$8.37K
Net Income	$-2,528,133.00
Revenue Growth (YoY)	N/A
Gross Margin	-9.70%
Operating Margin	-30,231.56%
Net Profit Margin	-30,231.56%
ROE	N/A
ROA · ROIC	-123.87% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	2,268.33
P/B	22.81
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	226.34M

Technical Indicators

50-Day SMA	$0.09
200-Day SMA	$0.10
RSI (14)	66.67
Beta	0.37
52-Week High	$0.14
52-Week Low	$0.05

Volume Today	104.31K
Avg Daily Volume (30D)	186.78K
Relative Volume	0.56x
Volatility (10D)	60.85
Volatility (30D)	64.17
Free Float	92.53%

Analyst Consensus

N/A

Current Price $0.12

Mean Target N/A

52W Low$0.05 52W High$0.14

Current

Target

$0.05 $0.14

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG00263KQP5

ISINCA92918C1014

CountryCanada

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine active pharmaceutical ingredients (API) and imaging contrast agents for medical radiology. It focuses on vertically integrating the barium and iodine contrast markets. In addition, Voyageur is pursuing the development of new endo fullerene drugs. Its products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. At the core of its operations, the Company also owns a 100% interest in the Frances Creek Project, which boasts a mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.